Saxagliptin (also known as Onglyza) is a common treatment for Type 2 diabetes. It can be used in combination with other drugs if warranted, and there is typically a prescribed exercise and nutrition plan that accompanies the use of this drug. The purpose of the drug is to help control blood sugar levels in patients diagnosed with Type 2 diabetes.
As with other medications, it carries warnings for side effects and potential complications, as well as adverse drug interactions. If you are seriously harmed, you can work with our attorneys to exercise your legal options to recover compensation.
Common Side Effects of Saxagliptin
Minor side effects have been associated with this dangerous drug, and the manufacturer offers information on these side effects on drug packaging and accompanying inserts or literature. Some of the more benign side effects can include runny or stuffy nose, cough, stomach pain, headache, or sore throat.
Some complications associated with this drug could be more serious and may warrant seeking legal help from our attorneys. More serious side effects include swelling of the extremities, painful or burning urination, or frequent or easy bruising or bleeding. It is also recommended that pregnant or breast-feeding women do not continue use without the recommendation of their physicians.
Saxagliptin can cause low blood sugar in some cases, and patients taking the drug should monitor blood sugar levels as recommended by their doctors. Signs of low blood sugar include tingling of the extremities, sudden and unexplained sweating, increased heart rate, dizziness, extreme hunger, blurry vision, or shaking.
Saxagliptin and Heart Failure
In February 2014, the FDA opened an analysis of the drug Saxagliptin. FDA officials have requested specific clinical trial data from the drug manufacturer in order to study a possible link between this drug and the occurrence of heart failure. The results of the study will be released by the FDA once conclusive evidence is evaluated.
The FDA evaluation of the link to Saxagliptin for heart failure was spurred by a study published in the New England Journal of Medicine (NEJM), which noted a correlation between it’s use and hospitalization for heart failure. Heart failure is the diagnosis given when the heart fails to pump blood through the body effectively. The NEJM study did not include evidence of increased incidences of death or medical heart-related conditions such as stroke or heart attacks.
While the FDA is investigating the possibility of this serious side effect, it does not consider the current information to be adequately conclusive. The current evaluation will also include other diabetes treatment drugs and their link to heart problems.
The FDA currently recommends that patients do not arbitrarily discontinue use of the drug; rather, that they speak with their physicians to gather more information and ask questions about any concerns they have. Any adverse reactions should be reported to the FDA via the MedWatch website.
Consult Saxagliptin Attorneys at Gacovino, Lake & Associates
While the FDA is still evaluating the potential risks, you might already have experienced damaging side effects as a result of using the drug. If you or a loved one suffered from heart failure or other complications linked to this drug, you may be entitled to compensation. The drug manufacturer could be responsible for reimbursing medical bills, lost wages and/or pain and suffering, so speak with our lawyers about your case.
Learn about your rights and how you can open a case against the responsible pharmaceutical company or a doctor who improperly prescribed the drug.
Gacovino, Lake & Associates is a law firm that specializes in defective drug cases, and we can help you decide what course of action will best benefit you and your family in the event that you suffered an illness or complication due to a drug manufacturer’s negligence. Call us today at 800-550-0000 to set up a consultation with our attorneys.